Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetic Study of Long-acting Antiretrovirals and Contraceptive Options in HIV Prevention

NCT07516548 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.

NCT NCT07516548
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07516548 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetic Study of Long-acting Antiretrovirals and Contraceptive Options in HIV Prevention
Lead sponsor
University of Alabama at Birmingham
Phase
Observational
Overall status
Recruiting
Start date
January 24, 2025
Completion date
December 31, 2026
Enrollment
105 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

contraception, drug-drug interaction, hiv infections, long-acting injectable cabotegravir for prep, prep